Ken Fisher's ARWR Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 1.31 M shares of Arrowhead Pharmaceuticals, Inc. (ARWR) worth $87.09 M, representing 0.03% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 7 quarters.
Based on 13F filings, Ken Fisher has maintained this position in ARWR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 602,139 shares. Largest reduction occurred in Q2 2025, reducing 31,598 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Arrowhead Pharmaceuticals (ARWR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Arrowhead Pharmaceuticals (ARWR) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +257,933 | Add 24.48% | 1.31 M | $66.39 |
| Q3 2025 | +602,139 | Add 133.32% | 1.05 M | $34.49 |
| Q2 2025 | -31,598 | Reduce 6.54% | 451,655 | $15.80 |
| Q1 2025 | +340,314 | Add 238.08% | 483,253 | $12.74 |
| Q4 2024 | +20,679 | Add 16.91% | 142,939 | $18.80 |
| Q3 2024 | +110,516 | Add 941.04% | 122,260 | $19.37 |
| Q2 2024 | +11,744 | New Buy | 11,744 | $25.99 |
Ken Fisher's Arrowhead Pharmaceuticals Investment FAQs
Ken Fisher first purchased Arrowhead Pharmaceuticals, Inc. (ARWR) in Q2 2024, acquiring 11,744 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Arrowhead Pharmaceuticals, Inc. (ARWR) for 7 quarters since Q2 2024.
Ken Fisher's largest addition to Arrowhead Pharmaceuticals, Inc. (ARWR) was in Q3 2025, adding 1,053,794 shares worth $36.35 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 1,311,727 shares of Arrowhead Pharmaceuticals, Inc. (ARWR), valued at approximately $87.09 M.
As of the Q4 2025 filing, Arrowhead Pharmaceuticals, Inc. (ARWR) represents approximately 0.03% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Arrowhead Pharmaceuticals, Inc. (ARWR) was 1,311,727 shares, as reported at the end of Q4 2025.